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Available online 19 March 2012AbstractBackground: Melioidosis has emerged as a global problem; however, few studies have specifically described the clinical characteristics and
outcomes when patients with melioidosis are treated at an emergency department (ED).
Purpose: The objective of this study was to examine the demographics and clinical characteristics of patients with melioidosis who visited an ED.
Methods: A retrospective analysis of patients treated for melioidosis at an ED.
Results: Of the 25 patients identified over 7 years, 22 patients had bacteremia, whereas diabetes mellitus was the most common underlying
disease (17 patients). Acute respiratory failure requiring mechanical ventilation developed in 52% of the patients. The overall mortality rate was
40%, and death within 48 hours of presentation at the ED occurred in 24% of the patients. The most common infection site was the lungs (in
52% of patients), and 36% of the patients presented with community-acquired pneumonia (CAP) at the ED. A comparison of the CAP and non-
CAP groups of patients revealed that the presence of shock upon arrival (56% vs. 0; p¼ 0.002), total mortality (78% vs. 19%; p¼ 0.009), and
early mortality (56% vs. 6%; p¼ 0.012) were significantly more common among the individuals who comprised the CAP group. Early mortality
accounted for 60% of total deaths, and all of these patients died before final microbiologic data were available. CAP presentation ( p¼ 0.012),
the presence of band-form leukocytes ( p¼ 0.001), increased serum creatinine ( p¼ 0.037), and shock on arrival ( p¼ 0.005) were significantly
more common among patients with early mortality.
Conclusion: Melioidosis is a devastating illness with a high rate of mortality occurring within 48 hours of presentation. Melioidosis that presents
with CAP is the most severe form of the disease and is associated with greatly increased early mortality.
Copyright  2012, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Melioidosis is an endemic disease of Southeast Asia and
northern Australia. With increasing worldwide travel, melioi-
dosis has emerged as a global problem.1 Infection usually
occurs after percutaneous inoculation or inhalation of Bur-
kholderia pseudomallei, which is present in the soil and surface* Corresponding author. Department of Emergency Medicine, Kaohsiung
Chang Gung Memorial Hospital, Chang Gung University College of Medicine,
Kaohsiung, Taiwan.
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doi:10.1016/j.jacme.2012.02.001water in endemic regions.2 The first case of melioidosis in
Taiwan was reported in 1985,3 and sporadic cases have been
reported thereafter. An outbreak of melioidosis occurred from
July 2005 to September 2005 after southern Taiwan was
struck by Typhoon Haitang, confirming that melioidosis is
endemic to the island.4,5
Melioidosis is nicknamed “the great mimicker” because of
its diverse clinical manifestations.6,7 Melioidosis clinically can
be asymptomatic, latent, chronically localized, or acutely sep-
ticemic. The acute septicemic form of melioidosis, in addition
to being frequently found as community-acquired pneumonia
(CAP) and/or fatal septicemia, may take the form of muscu-
loskeletal infection, urogenital infection, skin infection, brainMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
14 C.-H. Wu et al. / Journal of Acute Medicine 2 (2012) 13e18abscess, liver abscess, and splenic abscess; these forms have all
been reported in the literature and simulate a wide variety of
diseases.1,2,8 The mortality rate in patients with acute melioi-
dosis is high if the infection is not promptly diagnosed and
treated with timely and effective antibiotic therapy.8e12 The
clinical manifestations of melioidosis have been well studied,
but little is known about the disease’s clinical features and
outcomes among patients with melioidosis who are treated at
an emergency department (ED). The objective of this study was
to better understand the demographics and clinical character-
istics of patients with melioidosis who are treated in the ED.
2. Methods2.1. Patient selectionWe searched our hospital’s computerized microbiology
database for candidate individuals with melioidosis, and these
patients were included in this study. Candidates were patients
from whom a culture grown from any specimen was positively
identified as B pseudomallei. Culture specimens were obtained
between January 2001 and December 2007, and only patients
whose medical records showed that the culture specimen was
obtained during their visit to the ED were included in the
study. Patients who were not admitted to the hospital after
visiting the ED were excluded from the study. This study was
approved by the Institutional Review Board and the need for
informed consent was waived.2.2. Data collection and definitionsData were retrieved by retrospective review of patient
medical records including demographics, clinical manifesta-
tions, imaging findings, laboratory data, initial diagnoses
made at the ED, antimicrobial treatments, and outcomes. Soil
exposure was defined as contact with soil during either
occupational or recreational activity such as gardening,
farming, camping, or construction work. Excessive alcohol
consumption was defined as more than two drinks (20 g) per
day in women and more than three drinks (30 g) per day in
men.5 Shock on arrival was defined as a systolic blood pres-
sure below 90 mmHg or a decrease of more than 30 mmHg in
comparison with the patient’s baseline systolic blood pressure
detected at the ED, coupled with clinical evidence of periph-
eral hypoperfusion. Appropriate empiric antibiotic therapy
at the ED was defined as the start of empiric antibiotic treat-
ment, using imipenem, meropenem, ceftazidime, amoxicillin-
clavulanic acid, or trimethoprim-sulfamethoxazole, which
might be potentially effective against B pseudomallei.2
Suboptimal antimicrobial therapies refers to the inadequate
dosage of in vitro susceptible antibiotic agents. Early mortality
was defined as death within 48 hours after presentation at the
ED and before microbiologic confirmation. Pneumonia is the
most common presentation of melioidosis,8,9 and the patients
who were part of this study were divided into two groups
based on their clinical presentation at the ED. The CAP group
comprised patients who initially presented with fever, chills,cough, pleuritic chest pain, sputum production, and at least
one opacity on chest radiography; the non-CAP group
comprised patients who did not present with pneumonia-like
symptoms.2.3. Statistical analysisVariables from the two groups were compared. A Mann-
Whitney exact test was used to assess differences in the
continuous variables, whereas the Fisher exact test was used
to assess differences in dichotomous variables between the
two groups. Variables with p values less than 0.1 by
univariate analysis were separately entered into
a multivariate logistic regression model to identify
independent risk factors for early mortality in patients with
melioidosis. Variables with two-tailed p values less than 0.05
in multiple logistic regression were considered statistically
significant.
3. Results
One patient was admitted to the hospital from an orthopedic
outpatient clinic because of scheduled surgery for a herniated
intervertebral lumbar disc; excised necrotic tissue from this
patient was cultured and B pseudomallei was isolated 8 days
after the surgery; this patient was excluded from the study. A
total of 25 patients (mean age, 54 years; 92% male) with
melioidosis were included in the analysis; of these, 84% were
found to have at least one underlying condition, and diabetes
mellitus (in 68% of patients) was the most common disease.
Of the four patients (16%) with soil exposure, two were
farmers and two were construction workers. Sixteen of the
patients (64%) with melioidosis came to the ED during the
rainy season in Taiwan (between June and September). The
overall mortality rate was 40%, and early death within 48
hours after presentation at the ED occurred in 24% of the
patients. The demographic information on these patients is
presented in Table 1.
A descriptive analysis of the clinical characteristics of the
patients is presented in Table 2. The most common infection
site for melioidosis was the lungs (52%), followed by the
genitourinary tract (28%) and the joints (16%). Nine of the
patients (36%) had more than one site of infection. Of the 25
patients who were included in the study, acute respiratory
failure that required mechanical ventilatory support developed
in 13 (52%), and 22 (88%) had bacteremia. Of the five patients
(20%) who were in shock upon arrival, four died, which meant
that the mortality rate for patients suffering from shock was
80%. The time lapse between the blood and nonblood
sampling for culture and the availability of results indicating
B pseudomallei infection ranged from 3 to 8 days and 3 to 7
days, respectively. Only two patients (8%) were empirically
treated with amoxicillin-clavulanic acid but at a suboptimal
dosage for the treatment of melioidosis, whereas others
received inappropriate empiric antibiotic therapy. The
shortage of general wards and intensive care units is a serious
issue in medical centers in Taiwan; therefore, patients often
Table 1
Patients with melioidosis who presented to the emergency department.
No./sex/
age (yr)
Underlying condition(s) Site(s) of infection Positive culture (d to
sample analysis)
Shock
upon arrival
Initial empiric antibiotics Chief complaint/initial diagnosis Outcome
(survival days)
1/M/64 DM Prostate, spleen urinary tract Blood (5), urine (4) No Ceftriaxone Fever, dyspnea/FUO Alive
2/M/60 DM, alcohol Lung, urinary tract Blood (3), urine (4) Yes Ceftriaxone Fever, dyspnea/CAP Death (2)b
3/M/44 LC, hepatoma Primary bacteremia Blood (6) No Ceftriaxone Fever/FUO Death (17)
4/M/58 DM Lung Blood (7) No Cefuroxime and gentamicin Altered LOC/CAP Death (47)
5/M/52 DM Knee joint Blood (6), synovial fluid (7) No Cefazolin and gentamicin Right knee pain/septic arthritis Death (2)b
6/M/51 DM Prostate, kidney Blood (8) No Ceftriaxone Urinary retention/Urinary tract
infection
Alive
7/M/87 Stroke Lung Blood (6) Yes Cefuroxime Fever, cough/CAP Alive
8/F/40 SLE, steroid use Kidney Blood (5) No Cefuroxime Fever/FUO Alive
9/M/55 Renal cell carcinoma Prostate, urinary tract Urine (3) No Ceftriaxone Fever/urinary tract infection Alive
10/M/62 Hypertension Lung Blood (6) No Cefazolin and gentamicin Fever, cough/tuberculosis Alive
11/M/73 DM, LC, Hypertension Urinary tract Blood (4), urine (4) No Ceftriaxone Dysuria/urinary tract infection Alive
12/M/49 DM, hypertension Elbow joint Blood (5) No Cefazolin and gentamicin Chest pain, left arm pain/acute
coronary syndrome
Alive
13/M/40 None Primary bacteremia Blood (6) No Cefazolin and gentamicin Fever/FUO Alive
14/M/70 DM, CAD, CRF Eye, lung Blood (4), vitreous fluid (4) No Ceftriaxone Eye pain/endophthalmitis Death (9)
15/M/60 DM, LC, HCC Lung Blood (5) Yes Flomoxef Fever/CAP Death (2)b
16/M/50 DM, alcohol Lung Blood (4), sputum (3) No Moxifloxacin Fever, dyspnea/CAP Death (16)
17/M/60 DM Urinary tract, spine wound Blood (8), urine (3), wound (4) No Cefazolin and gentamicin Back pain/lumbar stenosis Alive
18/M/41 Alcohol, CRF Lung Blood (6) No Cefepime Cough, dyspnea/CAP Death (1)b
19/M/47 DM, LC Soft tissue Wound (4) No Cefazolin and gentamicin Leg pain/necrotizing fasciitis Alive
20/M/35 DM, LC, HCC Lung Blood (5) Yes Amoxicillin-clavulanic acida Fever, dyspnea/CAP Death (1)b
21/M/48 Alcohol Lung, mediastinal lymph node Blood (4), abscess (7) No Ceftriaxone and doxycycline Fever/FUO Alive
22/M/59 DM Lung, adrenal gland Blood (5), sputum (6) No Moxifloxacin Fever, cough/CAP Alive
23/F/44 DM Ankle joint Synovial fluid (4) No Oxacillin Ankle pain/septic arthritis Alive
24/M/38 DM, pancreatitis Lung, ankle joint Blood (7) No Oxacillin General weakness/nephrotic
syndrome
Alive
25/M/65 DM, hypertension, CAD Lung Blood (4) Yes Amoxicillin-clavulanic acida Fever, dyspnea, cough/CAP Death (1)b
Alcohol¼ excessive alcohol intake; CAD¼ coronary artery disease; CAP¼ community-acquired pneumonia; CRF¼ chronic renal failure; DM¼ diabetes mellitus; F¼ female; FUO¼ fever of unknown origin;
HCC¼ hepatocellular carcinoma; LC¼ liver cirrhosis; LOC¼ level of consciousness; M¼male; SLE¼ systemic lupus erythematosus.
a Initially appropriate empiric antibiotic therapy for melioidosis.
b Early mortality.
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Table 2
Demographics and clinical characteristics of the 25 patients with melioidosis.
Variables No.
Demographics
Mean age (years, range) 54 (35e87)
Sex ratio (male:female) 23:2
Risk factors for melioidosis (%)
Diabetes mellitus 17 (68)
Chronic renal failure 2 (8)
Excessive alcohol consumption 3 (12)
Liver cirrhosis 5 (20)
Malignancy 4 (16)
Occurrence during rainy season 16 (64)
Soil exposure 4 (16)
None identified 4 (16)
Infection site (%)
Lung 13 (52)
Genitourinary tract 7 (28)
Joint 4 (16)
Prostate gland 3 (12)
Kidney 2 (8)
Soft tissue 2 (8)
Primary bloodstream 2 (8)
Spleen 1 (4)
Adrenal gland 1 (4)
Mediastinum 1 (4)
Eye 1 (4)
Spine 1 (4)
More than one infection site 9 (36)
Clinical course
Hypotension on arrival (%) 5 (20)
Initially appropriate empiric antibiotic
therapy (%)
2 (8)
Mean time for microbiologic
culture confirmation (d, range)
(5, 3e8)
Laboratory data, mean (range)
WBCa (11.9, 4.0e26.5 109 cells/L)
CRPb (215, 2e652 mg/dL)
ASTc (73, 8e272 IU/L)
Creatinined (1.5, 0.5e5.4 mg/dL)
Glucosee (268, 28e675 mg/dL)
Bacteremia (%) 22 (88)
Clinical outcomes
Mechanical ventilation 13 (52)
Early mortality 6 (24)
Overall mortality 10 (40)
Mean length of hospital stay (d, range) (24, 1e51)
AST¼alanine aminotransferase; CRP¼C-reactive protein; WBC¼white
blood cells.
No. of available patients:
a n¼ 25.
b n¼ 20.
c n¼ 23.
d n¼ 25.
e n¼ 25.
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ranged from 1 to 6 days.
Patients with melioidosis exhibited variable presentations
upon arrival at the ED (Table 2). Overall, nine patients with
melioidosis presented to the ED with CAP and in another
four patients, in whom pneumonia was not initially present,
CAP developed at a later date. Pulmonary tuberculosis,endophthalmitis (occurring 3 days after arriving at the ED),
nephrotic syndrome (occurring 3 days after arriving at the ED),
and fever of unknown origin (occurring 4 days after arriving at
the ED) were initially diagnosed in these four patients. A
comparison of the clinical presentation on arrival at the ED
between the initial CAP and non-CAP groups revealed that
patients in the CAP group had a significantly higher frequency
of band-form leukocytes ( p¼ 0.012), higher levels of C-reac-
tive protein (CRP) ( p¼ 0.004), higher serum creatinine levels
( p¼ 0.038), and a higher frequency of shock on arrival (56%
vs. 0; p¼ 0.002). Poor outcomes were also found among the
patients in the CAP group, including a higher early mortality
rate (56% vs. 6%; p¼ 0.012) and a higher total mortality rate
(78% vs. 19%; p¼ 0.009), indicating that melioidosis pneu-
monia is the most severe form of the disease and this form of
melioidosis is associated with a tendency toward increased
early mortality.
There were six early deaths (60% of all mortalities) in our
study. Of these six patients, chief complaints were fever in five
and dyspnea in four. Four of these patients were treated at the
ED during the rainy season in Taiwan. Shock upon arrival was
present in four patients, and a rapid progression to pneumonia
occurred in five patients. Laboratory studies revealed elevated
CRP levels in four patients and band-form leukocytes in five
patients. The survival time was less than 24 hours for three
patients and between 24 and 48 hours for another three
patients.
A comparison of the clinical variables between the early
and nonearly mortality groups is shown in Table 3. There were
significant differences between these two groups, with a higher
proportion having band-form leukocytes ( p¼ 0.001), a higher
level of serum creatinine ( p¼ 0.037), a higher frequency of
initial presentation with CAP (83.3% vs. 21.1%; p¼ 0.012),
and a higher likelihood of shock on arrival at the ED
(66.7% vs. 5.3%; p¼ 0.005). Multivariate logistic regression
revealed that shock on arrival at the ED was an independent
risk factor for early mortality among patients with melioidosis
(odds ratio¼ 36.0, 95% confidence interval¼ 2.6e501.3;
p¼ 0.008).
4. Discussion
The reported in-hospital mortality rates for melioidosis
range in the literature from 19% to 68%.2,8 In our series, the
overall mortality rate was 40%, and death within 48 hours after
presentation to the ED occurred in 24% of patients, indicating
that melioidosis is a highly lethal infectious disease. However,
standard clinical diagnostic criteria for this infectious disease
have not yet been established for first-line physicians. Previous
studies have indicated that the variation in the clinical
presentation and the severity of the melioidosis may be due to
one or more of the following three factors: variation in
bacterial strain causing the infection including the presence or
absence of virulence factors, variation in the patient’s immune
response, and variation in the mode of acquisition.2
The prompt diagnosis of melioidosis is a great challenge to
ED physicians because of the disease’s diverse clinical
Table 3
Risk factors associated with early mortality among patients with melioidosis.
Early mortality
(n¼ 6), (%)
Nonearly mortality
(n¼ 19), (%)
p-valuec
Sex (male) 6 (100) 17 (89.5) 1.000
Mean age (years; range) 56 (35e68) 51 (38e87) 0.962
CAP presentation 5 (83.3) 4 (21.1) 0.012
Shock on arrivald 4 (66.7) 1 (5.3) 0.005
Mean WBC
( 109 cells/L; range)
17.8 (4.9e26.5) 8.6 (4.0e26.1) 0.303
Mean band WBC (%; range) 8 (5e14) 0 (0e13) 0.001
Mean CRP (mg/dL; range) 303 (139.2e380)a 180.2 (1.9e652.4)b 0.185
Mean glucose
(mg/dL; range)
369.5 (73e675) 223 (106e534) 0.176
Mean creatinine
(mg/dL; range)
1.9 (1.6e4.6) 1.1 (0.5e2.2) 0.037
Bacteremia 6 (100) 16 (84.2) 0.554
CAP¼ community-acquired pneumonia; CRP¼ C-reactive protein; WBC¼
white blood cells.
Number of available patients:
a n¼ 4.
b n¼ 16.
c Either Fisher exact test or the Mann-Whitney exact test was used for
comparison.
d Multivariate analysis indicated that shock on arrival was an independent
risk factor for early mortality (odds ratio¼ 36.0; 95% confidence inter-
val¼ 2.6e501.3; p¼ 0.008).
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obtaining bacteriologic identification that can result in inap-
propriate empiric antimicrobial selection and may place
patients at a greater risk for mortality. The isolation of B
pseudomallei from body fluids remains the gold standard for
the diagnosis of melioidosis. In our study, the mean duration
of time that lapsed before a culture confirming B pseudomallei
was obtained was 5 days (range, 3 to 8 days), and 60% of the
deaths in this study occurred before a confirmed culture was
available. Gram staining and other histopathologic stains are
not specific for this organism.13 A rapid and targeted micro-
biologic work-up, including techniques such as direct
microscopy with direct immunofluorescence14 and urinary
antigen enzyme-linked immunosorbent assays,15 might allow
a rapid provisional diagnosis to be made. Although many of
these rapid tests have been developed, few have been exten-
sively tested in the field. It needs to be noted that our data,
which include results showing that 80% of the total number of
patients who died had lung infections, 70% initially presented
with CAP on arrival at the ED, and that patients in whom
mortality occurs within 48 hours have a greater chance of
presenting with CAP at the ED compared with patients in
whom early mortality does not occur ( p¼ 0.012), suggest that
melioidosis pneumonia is the most severe form of the disease
and is associated with increased early mortality. The other
deaths in our series occurred on the 9th, 15th, 16th, and 47th day
after presentation at the ED and after culture results had
confirmed melioidosis. Accordingly, it is important for ED
physicians to differentiate between CAP and melioidosis
pneumonia to start timely and effective antibiotic therapy. Our
previous matched care-control study comparing patients with
melioidosis pneumonia and those with nonmelioid CAPshowed that visiting the ED during the rainy season, poor
control of glucose levels, and arriving in the ED in shock were
independent risk factors for patients with CAP caused by B
pseudomallei.16 Currie and Jacups17 also indicated that heavy
rainfall in the 14 days before admission was an independent
risk factor for pneumonia, septic shock, and death in patients
with melioidosis. It is postulated that heavy rainfall with
strong winds brings buried B pseudomallei isolates to the soil
surface; thereafter, they are more likely to be inhaled at high
concentrations causing pneumonic melioidosis; this may result
in the increased severity associated with septic shock and early
mortality. Furthermore, according to the review of Cheng
et al.,2 patients with diabetes mellitus in particular have
a higher incidence of melioidosis; up to 60% of patients with
melioidosis in this study had preexisting or newly diagnosed
type 2 diabetes. Other reported risk factors in studies with
a large series of patients with melioidosis include excessive
alcohol intake, chronic renal failure, soil/water exposure, and
chronic lung disease.2 It should be noted that liver cirrhosis
was the third leading underlying condition in our study. This
finding has not been reported in previous studies, but needs to
be taken into consideration as a risk factor for early diagnosis
of melioidosis in Taiwan. In addition, we found that 36% of
the patients in our series had more than one metastatic
infection site; in this context, previous reports have suggested
that melioidosis should be considered as a differential diag-
nosis for patients with fever and multiple metastatic infection
sites.8,11 It is necessary to remind ED physicians that melioi-
dosis should always be considered when a patient presents
with rapidly progressing pneumonia in the presence of
underlying risk factors and/or multiorgan involvement, espe-
cially after heavy rainfall.
Antimicrobial agents that are active against B pseudomallei
include imipenem, meropenem, ceftazidime, and amoxicillin-
clavulanic acid. Previous reports have revealed that inappro-
priate empiric antibiotic therapy is an independent risk factor
for mortality in community-acquired, as well as nosocomial-
acquired, bacteremia.18,19 In our study, all 23 patients
received inappropriate empiric antibiotics or appropriate
empirical antibiotics at a suboptimal dosage (2 patients) before
a positive culture of B pseudomallei was confirmed, which
suggests that ED physicians were unaware of melioidosis. This
finding highlights the importance of early diagnosis, especially
for the most severe forms of melioidosis seen in this study.
Two patients received appropriate empiric antibiotics before
a positive culture of B pseudomallei was confirmed, but the
clinical conditions of these two patients deteriorated rapidly,
and they died within 24 hours. Inadequate dosage (1200 mg
every 8 hours) of amoxicillin-clavulanic acid might be one of
the reasons for the treatment failure in these two patients. An
increased frequency of treatment (amoxicillin-clavulanic acid
20/4 mg/kg, intravenous, every 4 hours) to ensure adequate
levels of clavulanic acid in the bloodstream when treating
melioidosis has been suggested when melioidosis was sus-
pected in the ED.20
To the best of our knowledge, few studies have specifically
described the clinical course of individuals presenting with
18 C.-H. Wu et al. / Journal of Acute Medicine 2 (2012) 13e18melioidosis at the ED. We found that 6 of the 10 deaths (60%)
due to melioidosis occurred within 48 hours of arrival at ED.
Of these six patients, five had fulminate pneumonia and three
died within 24 hours of arrival at the ED. All five patients with
fulminate pneumonia were initially treated with respiratory
tract quinolones, a b-lactam/b-lactamase inhibitor, or a non-
anti-Pseudomonas-extended-range cephalosporin, which are
the preferred antimicrobial regimens for CAP according to the
current treatment guidelines developed by the Infectious
Diseases Society of America and the American Thoracic
Society.21 However, we found that the early mortality rate of
our patients with acute melioidosis pneumonia was 56%,
which is much higher than that observed for both patients with
CAP in the ED (2.5%)22 and patients with nonmelioid CAP
(18.3%) in our previous study.16 The current recommended
antimicrobial agents and dosages for CAP are not active
against B pseudomallei in vitro.2 A specific guideline for CAP
that is caused by B pseudomallei is needed in addition to
a locally adapted guideline for CAP treatment in an endemic
area. From the current study, we conclude that shock at the
time of ED arrival is an ominous sign of early mortality in
patients with melioidosis and that this is not specific to any
other form of septic shock. However, our study highlights the
fact that the early mortality rate of patients with acute
melioidosis pneumonia is much higher than that observed in
patients with CAP in the ED. It is necessary to remind ED
physicians that melioidosis is a devastating illness, with a high
rate of mortality within 48 hours after presentation at the ED,
and that early recognition and the choice of effective antibi-
otics is important.
There were several limitations in our study. First, one of the
shortcomings of our study is that it is a single-institution study
that described the hospital course of a small number of indi-
viduals in the ED. Second, the retrospective nature of the study
inevitably results in incomplete information collection
regarding the time of diagnosis and the time of initiation of
effective antimicrobial therapy in these patients. Thus, the
information regarding the appropriate timing of initiating
effective antimicrobial therapy for melioidosis in this study is
scarce. Moreover, because all of the patients received inap-
propriate or inadequate empiric antibiotic therapy in this study,
it is impossible to evaluate whether inappropriate empirical
antibiotic therapy is an independent risk factor for mortality
using the logistic regression model.
In conclusion, melioidosis is a devastating illness with
a high rate of mortality occurring within 48 hours after
presentation at the ED. Melioidosis with rapidly progressing
pneumonia, which is the most severe form of the disease, is
associated with increased early mortality. Melioidosis should
be considered as a differential diagnosis for any patient with
rapidly deteriorating CAP and/or sepsis with an acute fulmi-
nating course who presents to an ED in an endemic area,
especially after a typhoon or heavy rain.References
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